Semaglutide with B12 for weight loss — what the side effects actually look like

You've just started semaglutide and B12 together, and your stomach isn't happy

The scenario is familiar to a lot of people in the first few weeks: you've started your semaglutide pen, you're having B12 alongside it, and you feel rough. The question is whether you're reacting to the semaglutide, the B12, or both at once.

Semaglutide slows gastric emptying, food moves through your stomach more slowly than usual, which is part of why appetite drops. That same mechanism is responsible for most of the side effects people notice: nausea is the most reported, followed by loose stools or constipation, bloating, reflux, burping and fatigue. The full semaglutide side-effect picture is covered in detail elsewhere, but the key point is that these effects are typically sharpest in the first one to two weeks after a dose change, then settle for most people.

B12 injections, by contrast, have a very short side-effect list. The most common are redness, soreness or mild swelling at the injection site. A small number of people notice skin reactions (acne-like spots or itching) and very occasionally a flushing sensation shortly after the injection. Serious reactions are rare. The NHS semaglutide medicines page sets out the expected semaglutide profile clearly and is worth bookmarking during the early weeks of treatment.

When the two are used together, the overlapping symptoms are mainly fatigue and nausea. There is no established pharmacological interaction between B12 and semaglutide, but that does not mean you should assume every symptom is from one or the other. Keep a brief note of when symptoms arrive relative to each injection, it is exactly the kind of detail a prescriber finds useful.

When a side effect stops being something to ride out

Most gastrointestinal discomfort from semaglutide is unpleasant but not dangerous. There are, however, symptoms that should prompt you to seek medical help rather than wait.

Pancreatitis (inflammation of the pancreas) is an infrequent but serious side effect associated with GLP-1 medicines. In January 2026 the MHRA issued a Drug Safety Update specifically flagging this risk, advising that severe, persistent abdominal pain that may radiate to the back, with or without vomiting, requires urgent assessment. Stop the injection and contact a doctor or 111 promptly if that pattern fits what you're experiencing.

Other signs that need attention: symptoms of dehydration (dizziness, very dark urine, stopping urinating) if repeated vomiting has made it difficult to keep fluids down; any sign of an allergic reaction such as swelling of the face, lips or throat, or difficulty breathing; and sudden changes in mood or thoughts about self-harm, which should be taken seriously and discussed with a clinician immediately.

For a broader look at Wegovy's safety profile, including who the medicine is and isn't suitable for, our clinical team has put together a thorough guide. If you're unsure whether a symptom warrants a call, the answer is usually yes, and the aftercare team at our support line is available seven days a week.

Do these side effects ease over time, and what can help in the meantime?

For the majority of people, yes. The gastrointestinal effects of semaglutide tend to track the dose: they arrive when a new dose is introduced and, in most cases, reduce considerably within a couple of weeks as the body adjusts. Whether Wegovy side effects improve with time is a question patients frequently ask, and the honest answer is that the clinical evidence and patient experience both suggest they do, though the timeline varies.

Practical steps that tend to help during the adjustment period: eating smaller meals and stopping before you feel full, avoiding high-fat foods that delay gastric emptying further, staying well hydrated, and not lying down immediately after eating. If you store your pen in the fridge door (a common habit), checking it is at room temperature before injecting can also reduce localised discomfort at the site.

B12-related site reactions usually settle within 24 hours and respond to a cold compress. If they recur persistently or spread, mention it at your next review.

One thing worth saying plainly: pushing through severe nausea or reducing food intake aggressively because you want faster results is not the approach the medicine is designed for. Semaglutide works by reducing appetite; the calorie reduction follows naturally. Forcing the issue tends to worsen GI symptoms and can lead to inadequate protein intake, which matters for muscle retention. For more on long-term side-effect considerations, including what the evidence says beyond the first few months, there is further reading available.

Reporting side effects and getting the right support

If you experience a side effect you weren't expecting (from the semaglutide, from B12, or from a combination product) you can report it directly to the MHRA through the Yellow Card scheme. You don't need a clinician to submit a report; patients can do it themselves. It is one of the main ways regulators identify rare or unexpected reactions in real-world use, and it takes about ten minutes.

If you're already on treatment elsewhere and want a second clinical opinion, or you're considering starting semaglutide and want to understand your personal risk picture before committing, our prescribers cover both at consultation. Every review at nume includes a discussion of suitability and side effects based on your medical history, not a generic checklist. The side effects of taking Wegovy page walks through the specific Wegovy profile dose by dose, and our FAQs cover the questions our prescribers hear most often from people in the early weeks of treatment.